Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ramasubramanian Kalpatthi"'
Publikováno v:
Acta Paediatrica. 110:624-630
Aim We aimed to describe changes in invasive pneumococcal disease (IPD) hospitalisations after introduction of the pneumococcal conjugate vaccine (PCV13). Methods This was a retrospective analysis of the Pediatric Health Information System (PHIS) dat
Autor:
Troy Richardson, Enrico M. Novelli, Ramasubramanian Kalpatthi, Bradley A. Warady, Meghan McCormick
Publikováno v:
British Journal of Haematology. 189:559-565
Renal disease is a common complication experienced by patients with sickle cell disease (SCD), though the epidemiology of acute kidney injury (AKI) in paediatric patients and its impact on long-term renal outcomes is unclear. We utilized the Pediatri
Autor:
Miguel Reyes-Múgica, Deirdre Nolfi-Donegan, Ramasubramanian Kalpatthi, Marti Goldenberg, Subramanian Subramanian, Matthew Shiel
Publikováno v:
American journal of hematologyREFERENCES. 96(12)
Trends in Pediatric Primary Immunodeficiency: Incidence, Utilization, Transplantation, and Mortality
Publikováno v:
J Allergy Clin Immunol Pract
Background Primary immunodeficiency disorders (PIDDs) describe a myriad of diseases caused by inherited defects within the immune system. As the number of identified genetic defects associated with PIDDs increases, understanding the incidence and out
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 467, p 467 (2021)
Volume 11
Issue 6
Journal of Personalized Medicine, Vol 11, Iss 467, p 467 (2021)
Volume 11
Issue 6
Thrombotic microangiopathy (TMA) is a rare but serious complication of hematopoietic stem cell transplantation (HSCT). The purpose of our study is to estimate the incidence, prevalence, and analyze the risk factors and outcome of TMA in children rece
Autor:
Ramasubramanian Kalpatthi, Kenneth J. Smith, Meghan McCormick, Nalyn Siripong, Erika Friehling
Publikováno v:
Pediatr Blood Cancer
Background Infections are the leading cause of therapy-related mortality in pediatric patients with acute myeloid leukemia (AML). Although effectiveness of levofloxacin antibacterial prophylaxis in oncology patients is recognized, its cost-effectiven
Autor:
Eleanor A. Sharp, Robert T. Krafty, Jun Zhang, Ramasubramanian Kalpatthi, Sripriya Raman, Meghan McCormick, Nursen Gurtunca, James Zullo
Publikováno v:
Pediatr Blood Cancer
Background Hyperglycemia is a complication of induction chemotherapy in 10%-50% of pediatric patients with acute lymphoblastic leukemia (ALL). Though hyperglycemia in ALL patients is usually transient, it may be associated with adverse health outcome
Publikováno v:
Journal of Pediatric Hematology/Oncology. 33:399-400